Folinsyre og svangerskap - Sikker kunnskap, usikker praksis

Tidsskrift for den Norske Laegeforening

Volumn 116, Issue 2, 1996, Pages 217-218

  Vollset, Stein Emil ^a   Irgens, Lorentz M ^a  

^a Armauer Hansens Hus   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

ADVERSE DRUG REACTION; DRUG USE; EDITORIAL; FEMALE; HUMAN; NORWAY; NUTRITION; PREGNANCY;

ABNORMALITIES; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; HEMATINICS; HUMANS; NORWAY; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 3142638797     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Conway II. Effect of supplemental vitamin therapy on the limitation of incidence of cleft lip and cleft palate in humans. Plast Reconstr Surg 1958; 22: 450-3.
2. Hibbard BM. The role of folic acid in pregnancy with particular reference to anemia, abruption and abortion. J Obstet Gynaecol Br Commonw 1964; 71: 529-42.
3. Hibbard ED, Smithells RW. Folic acid metabolism and human embryopathy. Lancet 1965, 1: 1254.
4. Christensen B. Folatmangel, kreft og medfødte misdannelser, Tidsskr Nor Lægeforen 1996; 116: 250-4.
5. Report from an Expert Advisory Group. Folic acid and the prevention of neural tube defects. London: Department of Health, 1992.
6. Centers for Disease Control. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Morb Mortal Wkly Rep 1992; 41: RR-14. Gjengitt i JAMA 1993; 269: 1233-8.
7. Centers for Disease Control. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Morb Mortal Wkly Rep 1992; 41: RR-14. Gjengitt i JAMA 1993; 269: 1233-8.
8. Tiltak som kan redusere forekomst av nevralrersdefekter. Rundskriv IK-4/93. Oslo: Statens, helsetilsyn, 1993.
9. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338: 131-7.
10. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327: 1832-5.
11. Czeizel AE. Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ 1993; 306: 1645-8.
12. Shaw GM, Schaffer D, Velie EM, Morland K, Hams JA. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 1995; 6: 219-26.
13. Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 1993; 269: 1257-61.
14. Shaw GM, Lammer EJ, Wasserman CR, O'Malley CD, Tolarova MM. Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet 1995; 345: 393-6.
15. Li DK, Daling JR, Mueller BA, Hickok DE, Fantel AG, Weiss NS. Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies. Epidemiology 1995; 6: 212-8.
16. Bower C. Epilepsy in pregnancy: neural tube defects and folate. Med J Aust 1994; 160: 56-7.
17. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049-57.
18. Wouters MGAJ, Boers GHJ, Blom HJ, Trijbels FJM, Thomas CMG, Borm GF et al. Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril 1993; 60: 820-5.
19. Steegers-Theunissen RPM, Boers GHJ. Blom HJ, Trijbels FJM, Eskes TKAB. Hyperhomocysteinaemia and recurrent spontaneous abortion or abruptio placentae. Lancet 1992; 339: 1122-3.
20. Willett WC. Folic acid and neural tube defeet: can't we come to closure? Am J Public Health 1992; 82: 666-8.
21. Wald NJ, Bower C. Folic acid and the prevention of neural tube defects. A population strategy is needed. BMJ 1995; 310: 1019-20.